These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 26592910)

  • 1. An antibiotic recipe for an arrhythmic disaster.
    McCutcheon K; Manga P
    Cardiovasc J Afr; 2015; 26(3):143-5. PubMed ID: 26592910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of ventricular pacing in the treatment of an arrhythmic storm associated with a congenital long QT mutation.
    Aziz PF; Shah MJ
    Congenit Heart Dis; 2013; 8(6):E165-7. PubMed ID: 23075154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of erythromycin-induced malignant tachyarrhythmia--torsade de pointes. A case report.
    Katapadi K; Kostandy G; Katapadi M; Hussain KM; Schifter D
    Angiology; 1997 Sep; 48(9):821-6. PubMed ID: 9313632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early afterdepolarization in a patient with complete atrioventricular block and torsades de pointes.
    Kurita T; Ohe T; Shimizu W; Hotta D; Shimomura K
    Pacing Clin Electrophysiol; 1993 Jan; 16(1 Pt 1):33-8. PubMed ID: 7681173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AV-block and conduction slowing prevail over TdP arrhythmias in the methoxamine-sensitized pro-arrhythmic rabbit model.
    Varkevisser R; Vos MA; Beekman JD; Tieland RG; Van Der Heyden MA
    J Cardiovasc Electrophysiol; 2015 Jan; 26(1):82-9. PubMed ID: 25154623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Torsade de pointes in a patient with complete atrioventricular block and pacemaker failure, misdiagnosed with epilepsy.
    Cai SY; Ye SF; Wu X; Xiang MX; Wang JA
    J Electrocardiol; 2015; 48(3):450-4. PubMed ID: 25771702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interesting case of pre-excitation masking complete atrioventricular block.
    Mohanan Nair KK; Meerakutty SB; Namboodiri N; Valaparambil A
    J Cardiovasc Electrophysiol; 2019 Aug; 30(8):1375-1377. PubMed ID: 31187599
    [No Abstract]   [Full Text] [Related]  

  • 8. Hydroxyzine-induced Torsade de Pointes in a Patient with Complete Atrioventricular Block.
    Koshino K; Endo A; Watanabe N; Okazaki K; Tanabe K
    Intern Med; 2021 Oct; 60(20):3257-3260. PubMed ID: 33896871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of erythromycin on myocardial repolarization in patients with community-acquired pneumonia.
    Kdesh A; McPherson CA; Yaylali Y; Yasick D; Bradley K; Manthous CA
    South Med J; 1999 Dec; 92(12):1178-82. PubMed ID: 10624910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clarithromycin induced torsade de pointes.
    Hensey C; Keane D
    Ir J Med Sci; 2008 Mar; 177(1):67-8. PubMed ID: 17618400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythromycin induced Torsades de Pointes: case report and review of the literature.
    Rezkalla MA; Pochop C
    S D J Med; 1994 May; 47(5):161-4. PubMed ID: 8047870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pacemaker malfunction or non-physiological ventricular pacing?
    Pérez OC; Sancho-Tello de Carranza MJ; Asensi JO; Olagüe de Ros JA
    Europace; 2008 Feb; 10(2):161-3. PubMed ID: 18208939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management and outcome of topical beta-blocker-induced atrioventricular block.
    Özcan KS; Güngör B; Osmonov D; Tekkeşin AI; Altay S; Ekmekçi A; Toprak E; Yildirim E; Çalik N; Alper AT; Gürkan K; Erdinler I
    Cardiovasc J Afr; 2015; 26(6):210-3. PubMed ID: 26659434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-induced torsades de pointes in one patient with congenital long QT syndrome.
    Hsieh MH; Chen SA; Chiang CE; Tai CT; Lee SH; Wen ZC; Chang MS
    Int J Cardiol; 1996 Apr; 54(1):85-8. PubMed ID: 8792191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Old habits die hard: the quest for correct(ed) QT interval measurements.
    Husser D; Hindricks G
    J Cardiovasc Electrophysiol; 2010 Aug; 21(8):914-5. PubMed ID: 20626523
    [No Abstract]   [Full Text] [Related]  

  • 16. Preferred QT correction formula for the assessment of drug-induced QT interval prolongation.
    Chiladakis J; Kalogeropoulos A; Arvanitis P; Koutsogiannis N; Zagli F; Alexopoulos D
    J Cardiovasc Electrophysiol; 2010 Aug; 21(8):905-13. PubMed ID: 20233271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Takotsubo cardiomyopathy associated with complete atrioventricular block and Torsades de pointes.
    Oshima T; Ikutomi M; Ishiwata J; Shinohara H; Ouchi K; Kozaki T; Amaki T; Nakamura F
    Int J Cardiol; 2015 Feb; 181():357-9. PubMed ID: 25555279
    [No Abstract]   [Full Text] [Related]  

  • 18. QT prolongation and torsades de pointes associated with concurrent use of cisapride and erythromycin.
    Kyrmizakis DE; Chimona TS; Kanoupakis EM; Papadakis CE; Velegrakis GA; Helidonis ES
    Am J Otolaryngol; 2002; 23(5):303-7. PubMed ID: 12239699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moxifloxacin and torsade de pointes.
    Dale KM; Lertsburapa K; Kluger J; White CM
    Ann Pharmacother; 2007 Feb; 41(2):336-40. PubMed ID: 17284508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of torsades de pointes from oral erythromycin with concomitant carbimazole (methimazole) administration.
    Koh TW
    Pacing Clin Electrophysiol; 2001 Oct; 24(10):1575-6. PubMed ID: 11707056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.